Replay: Hedgeye House Call + Q&A (1/18) | The Doctor is In | The '22 Re-Opening, COVID, & Labor

01/18/22 04:25PM EST

LIVE Q&A

We're looking at a potentially great setup for February as we work our way into the New Year.  Omicron's wildfire-like spread since our last House Call (12/6) has been right on the heels of, and perhaps overlapping with, the Delta wave in some regions, and proved that even a mild[er] SARS-CoV-2 variant can be both highly disruptive and dangerous (for people and the system).  Tom reviewed the Macro Quad transition (Quad 1/4), why we expect COVID-related data to improve from here, and then Tom and Will discussed several of our Position Monitor stocks (throughout the prepared comments and during the Q&A  - see time stamps below).  Concurrently, we're seeing the Acceleration of forward estimates hook up a bit in our screening data, which is included in the presentation materials this week (please note, our usual MicroQuads & Estimate Trend update note will resume on 1/24). 

Hedgeye House Call + Q&A | The Doctor is In | Jan 18, 12:30 PM | The '22 Re-Opening, COVID, & Labor 

Health Care Subscribers: CLICK HERE for event details (including video, materials links, and Q&A box)

Replay: Hedgeye House Call + Q&A (1/18) | The Doctor is In | The '22 Re-Opening, COVID, & Labor - 1 18 2022 House Call Replay

Topics & time Stamps

00:30 - Intro and shift to Macro Quad 4 outlook; implications for Health Care.

09:04 - MicroQuads & Estimate Revision Trend - impact of Delta then labor and Omicron (where we are now and why 1Q22 might not look good); MicroQuad bins (13:31)

17:37 - One Medical (ONEM) provider tracker - ability to hire and retain clinicians

20:45 - COVID-19 Trends Update (Inpatient vs. ICU, Inpatient Utilization)

22:29 - Labor update - demand, critical staffing levels, psych hospitals (AMN, ACHC)

25:50 - GoodRx (GDRX) Google Trend update & PCE trends

27:46 - Teladoc (TDOC), BetterHelp app data

29:02 - Quest Diagnostics (DGX) update

30:42 - Q&A

  • 30:48 - ONEM: PODs vs. Quads, OSH and CANO, cohorts, etc.
  • 37:46 - LFST: update & outlook (importance of hiring clinicians)
  • 41:00 - ACHC: update, recent M&A
  • 44:55 - ATIP: update, hiring trend "OK" into year's end '21, no change to thesis
  • 48:21 - ACHC: why behavioral is a better short than acute care
  • 49:20 - DGX: potential to flip back to long later this year

As always, all data available upon request, and reach out to  with any inquiries.

Thomas Tobin
Managing Director


Twitter
LinkedIn

William McMahon
Analyst


Twitter
LinkedIn

Justin Venneri
Director, Primary Research


Twitter
LinkedIn

© 2024 Hedgeye Risk Management, LLC. The information contained herein is the property of Hedgeye, which reserves all rights thereto. Redistribution of any part of this information is prohibited without the express written consent of Hedgeye. Hedgeye is not responsible for any errors in or omissions to this information, or for any consequences that may result from the use of this information.